C‐EDGE CO‐STAR: RISK OF REINFECTION FOLLOWING SUCCESSFUL THERAPY WITH ELBASVIR (EBR) AND GRAZOPREVIR (GZR) IN PERSONS WHO INJECT DRUGS (PWID) RECEIVING OPIOID AGONIST THERAPY (OAT). Issue 4 (December 2016) - Conway, B; Dore, G J; Altice, F; Litwin, A H; Grebely, J; Dalgard, O; Gane, E J; Shibolet, O; Luetkemeyer, A; Nahass, R; Peng, C‐Y1; Gendrano, I N; et al.